• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全免疫炎症值在确定非ST段抬高型心肌梗死患者冠状动脉疾病严重程度中的作用

The Role of Pan-Immune-Inflammation Value in Determining the Severity of Coronary Artery Disease in NSTEMI Patients.

作者信息

Cetinkaya Zeki, Kelesoglu Saban, Tuncay Aydin, Yilmaz Yucel, Karaca Yucel, Karasu Mehdi, Secen Ozlem, Cinar Ahmet, Harman Murat, Sahin Seyda, Akin Yusuf, Yavcin Ozkan

机构信息

Department of Cardiology, Ministry of Health, Elazıg Fethi Sekin City Hospital, Elazıg 23280, Turkey.

Department of Cardiology, Erciyes University Faculty of Medicine, Kayseri 38039, Turkey.

出版信息

J Clin Med. 2024 Feb 25;13(5):1295. doi: 10.3390/jcm13051295.

DOI:10.3390/jcm13051295
PMID:38592192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10931938/
Abstract

BACKGROUND

Even though medication and interventional therapy have improved the death rate for non-ST elevation myocardial infarction (NSTEMI) patients, these patients still have a substantial residual risk of cardiovascular events. Early identification of high-risk individuals is critical for improving prognosis, especially in this patient group. The focus of recent research has switched to finding new related indicators that can help distinguish high-risk patients. For this purpose, we examined the relationship between the pan-immune-inflammation value (PIV) and the severity of coronary artery disease (CAD) defined by the SYNTAX score (SxS) in NSTEMI patients.

METHODS

Based on the SxS, CAD patients were split into three groups. To evaluate the risk variables of CAD, multivariate logistic analysis was employed.

RESULTS

The PIV (odds ratio: 1.003; 95% CI: 1.001-1.005; = 0.005) was found to be an independent predictor of a high SxS in the multivariate logistic regression analysis. Additionally, there was a positive association between the PIV and SxS (r: 0.68; < 0.001). The PIV predicted the severe coronary lesion in the receiver-operating characteristic curve analysis with a sensitivity of 91% and specificity of 81.1%, using an appropriate cutoff value of 568.2.

CONCLUSIONS

In patients with non-STEMI, the PIV, a cheap and easily measured laboratory variable, was substantially correlated with a high SxS and the severity of CAD.

摘要

背景

尽管药物治疗和介入治疗已降低了非ST段抬高型心肌梗死(NSTEMI)患者的死亡率,但这些患者仍存在心血管事件的显著残余风险。早期识别高危个体对于改善预后至关重要,尤其是在该患者群体中。近期研究的重点已转向寻找有助于区分高危患者的新相关指标。为此,我们研究了NSTEMI患者的全免疫炎症值(PIV)与由SYNTAX评分(SxS)定义的冠状动脉疾病(CAD)严重程度之间的关系。

方法

根据SxS,将CAD患者分为三组。采用多因素逻辑分析评估CAD的风险变量。

结果

在多因素逻辑回归分析中,发现PIV(比值比:1.003;95%置信区间:1.001 - 1.005;P = 0.005)是高SxS的独立预测因子。此外,PIV与SxS之间存在正相关(r:0.68;P < 0.001)。在接受者操作特征曲线分析中,PIV预测严重冠状动脉病变的敏感性为91%,特异性为81.1%,合适的临界值为568.2。

结论

在非STEMI患者中,PIV作为一种廉价且易于测量的实验室变量,与高SxS及CAD严重程度显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609e/10931938/979d1f11391c/jcm-13-01295-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609e/10931938/411875202c32/jcm-13-01295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609e/10931938/979d1f11391c/jcm-13-01295-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609e/10931938/411875202c32/jcm-13-01295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609e/10931938/979d1f11391c/jcm-13-01295-g002.jpg

相似文献

1
The Role of Pan-Immune-Inflammation Value in Determining the Severity of Coronary Artery Disease in NSTEMI Patients.全免疫炎症值在确定非ST段抬高型心肌梗死患者冠状动脉疾病严重程度中的作用
J Clin Med. 2024 Feb 25;13(5):1295. doi: 10.3390/jcm13051295.
2
Relationship Between Systemic Immune-Inflammation Index (SII) and the Severity of Stable Coronary Artery Disease.全身免疫炎症指数(SII)与稳定型冠状动脉疾病严重程度的关系
Angiology. 2021 Jul;72(6):575-581. doi: 10.1177/0003319720987743. Epub 2021 Mar 9.
3
Correlation and prognostic role of neutrophil to lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: A six-year experience.中性粒细胞与淋巴细胞比值及SYNTAX评分在接受经皮冠状动脉介入治疗的急性心肌梗死患者中的相关性及预后作用:一项六年的经验。
Cardiovasc Revasc Med. 2017 Dec;18(8):565-571. doi: 10.1016/j.carrev.2017.05.007. Epub 2017 May 12.
4
Predictive value of newly defined CHA2DS2-VASc-HSF score for severity of coronary artery disease in ST segment elevation myocardial infarction.新定义的CHA2DS2-VASc-HSF评分对ST段抬高型心肌梗死患者冠状动脉疾病严重程度的预测价值
Kardiol Pol. 2016;74(9):954-60. doi: 10.5603/KP.a2016.0054. Epub 2016 Apr 26.
5
Pan-Immune-Inflammatory Value is Superior to Other Inflammatory Indicators in Predicting Inpatient Major Adverse Cardiovascular Events and Severe Coronary Artery Stenosis after Percutaneous Coronary Intervention in STEMI Patients.全免疫炎症值在预测ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后的住院主要不良心血管事件和严重冠状动脉狭窄方面优于其他炎症指标。
Rev Cardiovasc Med. 2024 Aug 20;25(8):294. doi: 10.31083/j.rcm2508294. eCollection 2024 Aug.
6
Systemic Immune-Inflammatory Index Is Associated with Residual SYNTAX Score in Patients with ST-Segment Elevation Myocardial Infarction.系统免疫炎症指数与 ST 段抬高型心肌梗死患者残余 SYNTAX 评分相关。
Anatol J Cardiol. 2023 Aug 1;27(8):472-478. doi: 10.14744/AnatolJCardiol.2023.3074. Epub 2023 Jun 7.
7
The Role of Pan-Immune-Inflammation Value in Predicting Contrast-Induced Nephropathy Development in Patients Undergoing Percutaneous Coronary Intervention Due to NSTEMI.全免疫炎症值在预测因非ST段抬高型心肌梗死接受经皮冠状动脉介入治疗患者造影剂诱导的肾病发生中的作用
Angiology. 2025 Mar;76(3):281-288. doi: 10.1177/00033197231211107. Epub 2023 Oct 30.
8
Does SYNTAX score predict in-hospital outcomes in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention?SYNTAX评分能否预测接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的院内结局?
Kardiol Pol. 2014;72(9):806-13. doi: 10.5603/KP.a2014.0064. Epub 2014 Mar 27.
9
Relationship Between the Fibrinogen-to-Albumin Ratio and SYNTAX Score in Patients with Non-St-Elevation Myocardial Infarction.非ST段抬高型心肌梗死患者纤维蛋白原与白蛋白比值和SYNTAX评分的关系
Rev Invest Clin. 2021 Feb 3;73(3):182-189. doi: 10.24875/RIC.20000534.
10
Procalcitonin is an independent predictor for coronary atherosclerotic burden in patients with stable coronary artery disease.降钙素原是稳定型冠状动脉疾病患者冠状动脉粥样硬化负担的独立预测指标。
Int J Cardiol. 2017 Jun 1;236:61-64. doi: 10.1016/j.ijcard.2017.02.061. Epub 2017 Feb 21.

引用本文的文献

1
Investigation of the relationship between the triglyceride-glucose index and metabolic and hematological parameters in obese individuals.肥胖个体中甘油三酯-葡萄糖指数与代谢和血液学参数之间关系的研究。
Turk J Med Sci. 2025 Apr 12;55(3):710-718. doi: 10.55730/1300-0144.6019. eCollection 2025.
2
A New Perspective on NSTE-ACS Patients in the Emergency Department: Cardiac Risk Prediction with New Inflammation Markers.急诊科非ST段抬高型急性冠脉综合征患者的新视角:利用新型炎症标志物进行心脏风险预测
Med Sci Monit. 2025 Jul 2;31:e948699. doi: 10.12659/MSM.948699.
3
Galectin-3 and Pentraxin-3 as Potential Biomarkers in Chronic Coronary Syndrome and Atrial Fibrillation: Insights from a 131-Patient Cohort.

本文引用的文献

1
Pan-Immune-Inflammation Value Is Independently Correlated to Impaired Coronary Flow After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.在 ST 段抬高型心肌梗死患者中,全免疫炎症值与经皮冠状动脉介入治疗后冠状动脉血流受损独立相关。
Am J Cardiol. 2024 Jan 15;211:153-159. doi: 10.1016/j.amjcard.2023.10.088. Epub 2023 Nov 8.
2
The Role of Pan-Immune-Inflammation Value in Predicting Contrast-Induced Nephropathy Development in Patients Undergoing Percutaneous Coronary Intervention Due to NSTEMI.全免疫炎症值在预测因非ST段抬高型心肌梗死接受经皮冠状动脉介入治疗患者造影剂诱导的肾病发生中的作用
Angiology. 2025 Mar;76(3):281-288. doi: 10.1177/00033197231211107. Epub 2023 Oct 30.
3
半乳糖凝集素-3和五聚素-3作为慢性冠状动脉综合征和心房颤动的潜在生物标志物:来自131例患者队列的见解
Int J Mol Sci. 2025 May 20;26(10):4909. doi: 10.3390/ijms26104909.
4
Association Between Pan-Immune-Inflammation Value and Dipper/Non-Dipper Status in Newly Diagnosed Hypertensive Patients.初诊高血压患者全免疫炎症值与杓型/非杓型状态之间的关联
J Inflamm Res. 2025 May 13;18:6217-6228. doi: 10.2147/JIR.S522032. eCollection 2025.
5
Inflammatory Markers and Saphenous Vein Graft Stenosis: Insights into the Use of Glucose-to-Lymphocyte Ratio as a Prognostic Marker.炎症标志物与大隐静脉移植血管狭窄:关于葡萄糖与淋巴细胞比值作为预后标志物应用的见解
J Clin Med. 2025 Apr 11;14(8):2634. doi: 10.3390/jcm14082634.
6
Prognostic Role of Pan-Immune-Inflammatory Value in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome.全免疫炎症值在非ST段抬高型急性冠状动脉综合征患者中的预后作用
J Cardiovasc Dev Dis. 2025 Feb 18;12(2):79. doi: 10.3390/jcdd12020079.
7
Automatic Detection of Occluded Main Coronary Arteries of NSTEMI Patients with MI-MS ConvMixer + WSSE Without CAG.无需冠状动脉造影(CAG),使用MI-MS ConvMixer + WSSE自动检测非ST段抬高型心肌梗死(NSTEMI)患者的闭塞主要冠状动脉
Diagnostics (Basel). 2025 Feb 2;15(3):347. doi: 10.3390/diagnostics15030347.
8
Looking Back, Leaning Forward-A Contemporary Overview of Acute Coronary Syndrome.回首往昔,展望未来——急性冠状动脉综合征的当代概述
J Clin Med. 2024 Dec 2;13(23):7331. doi: 10.3390/jcm13237331.
9
Association of RDW-Albumin Ratio, TG-Glucose Index, and PIV with Coronary Artery Disease.红细胞分布宽度-白蛋白比值、甘油三酯-葡萄糖指数及血小板体积与冠心病的关联
J Clin Med. 2024 Nov 21;13(23):7003. doi: 10.3390/jcm13237003.
10
Predictive Value of Pan-Immune Inflammation Value and Systemic Immune-Inflammation Index for Identifying Coronary Vulnerable Plaques: New Insights from Optical Coherence Tomography in Acute Coronary Syndrome Patients.全免疫炎症值和全身免疫炎症指数对识别冠状动脉易损斑块的预测价值:急性冠状动脉综合征患者光学相干断层扫描的新见解
J Inflamm Res. 2024 Dec 4;17:10371-10382. doi: 10.2147/JIR.S498292. eCollection 2024.
Association of Systemic Inflammatory Response Index and Pan-Immune-Inflammation-Value with Long-Term Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention.
ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后全身炎症反应指数和全免疫炎症值与长期不良心血管事件的关联
J Inflamm Res. 2023 Aug 14;16:3437-3454. doi: 10.2147/JIR.S421491. eCollection 2023.
4
Pan-immune-inflammation Value and Prognosis in Patients With Esophageal Cancer.食管癌患者的全免疫炎症值与预后
Ann Surg Open. 2021 Dec 22;3(1):e113. doi: 10.1097/AS9.0000000000000113. eCollection 2022 Mar.
5
Association between pan-immune-inflammation value and no-reflow in patients with ST elevation myocardial infarction undergoing percutaneous coronary intervention.接受经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者全免疫炎症值与无复流之间的关联。
Scand J Clin Lab Invest. 2023 Oct;83(6):384-389. doi: 10.1080/00365513.2023.2241131. Epub 2023 Jul 27.
6
Comparison of Different Systemic Inflammatory Markers in Predicting Clinical Outcomes with Syntax Score in Patients with Non-ST Segment Elevation Myocardial Infarction: A Retrospective Study.非ST段抬高型心肌梗死患者中不同全身炎症标志物与Syntax评分预测临床结局的比较:一项回顾性研究
Int J Gen Med. 2023 Jun 19;16:2595-2607. doi: 10.2147/IJGM.S413538. eCollection 2023.
7
The Prognostic Value of Hematologic Inflammatory Markers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.血液炎症标志物对行经皮冠状动脉介入治疗的急性冠状动脉综合征患者的预后价值。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221146183. doi: 10.1177/10760296221146183.
8
Can Automating the SYNTAX Score Move Practice Beyond the Angiogram Alone?SYNTAX评分自动化能否推动实践超越单纯的血管造影?
JACC Cardiovasc Interv. 2022 Dec 26;15(24):2487-2489. doi: 10.1016/j.jcin.2022.10.056.
9
Increased Serum Systemic Immune-Inflammation Index is Independently Associated With Severity of Carotid Artery Stenosis.血清系统免疫炎症指数升高与颈动脉狭窄严重程度独立相关。
Angiology. 2023 Sep;74(8):790-797. doi: 10.1177/00033197221144934. Epub 2022 Dec 7.
10
Comparison of pan-immune-inflammation value with other inflammation markers of long-term survival after ST-segment elevation myocardial infarction.ST段抬高型心肌梗死后长期生存的泛免疫炎症值与其他炎症标志物的比较。
Eur J Clin Invest. 2023 Jan;53(1):e13872. doi: 10.1111/eci.13872. Epub 2022 Sep 20.